Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Objective: To quantify structural changes in the substantia nigra of patients with PD with inversion recovery MRI and to compare these with striatal dopaminergic function measured with 18SF-dopa PET. Methods: The authors studied 10 patients with PD and eight age-matched control subjects with a combination of MR sequences previously reported to be sensitive to nigral cell loss. Striatal regions of interest were defined on T1-weighted MRI coregistered to 18SF-dopa PET in all subjects. Results: Discriminant function analysis of the quantified MR nigral signal correctly classified 83% of the combined PD patient/control group; three of 10 PD cases were incorrectly classified as "normal" (Wilks' λ = 0.724, p > 0.05). Discriminant function analysis correctly classified 100% of PD patients and control subjects with 18SF-dopa PET based on mean caudate and putamen Ki values (Wilks' λ = 0.065, p < 0.001). Correlations between mean putamen Ki and rostral and caudal nigral MR signal changes and mean caudate Ki and caudal nigral MR signal changes were found (r = -0.76, -0.69, -0.80, p < 0.05). Conclusion: 18F-dopa PET is more reliable than inversion recovery MRI in discriminating patients with moderately severe PD from normal subjects. However, the structural changes detected within the substantia nigra of patients with PD found using inversion recovery MRI correlate with measures of striatal dopaminergic function using 18F-dopa PET.

Original publication

DOI

10.1212/WNL.56.9.1195

Type

Journal article

Journal

Neurology

Publication Date

08/05/2001

Volume

56

Pages

1195 - 1200